The import of therapeutic respiration apparatus to the US has shown steady growth with forecast values increasing from $2.86 billion in 2024 to $3.18 billion by 2028. Compared to the actual figure for 2023, which stood at approximately $2.78 billion, the projected growth is evident. The year-on-year growth rate from 2024 to 2025 is approximately 2.83%, while from 2025 to 2026, it's about 2.70%. The compounded annual growth rate (CAGR) over the five-year forecast period is around 2.67%.
Future trends to watch include technological advancements in therapeutic respiration devices, fluctuating healthcare policies, and potential shifts in global trade relations that could impact import volumes and costs.
